Jaime Rosa Duque | Immunology | Best Researcher Award

Dr. Jaime Rosa Duque | Immunology | Best Researcher Award

Dr. Jaime Rosa Duque, The University of Hong Kong, Hong Kong

Dr. Jaime Sou Da Rosa Duque, MD, PhD, is a Clinical Assistant Professor at the University of Hong Kong specializing in paediatric immunology, allergy, and infectious diseases. He holds multiple board certifications and has completed fellowships at Stanford University. With extensive experience in paediatrics, he has contributed significantly to allergy research and immunology. His dedication to advancing child health has earned him honorary appointments and numerous awards, making him a distinguished leader in his field. 🌍🏅

Publication Profile

Orcid

🎓 Education

Dr. Duque earned his MD with Distinction in Research from the University of California, Irvine, and a PhD in Pharmacology and Toxicology. He holds a BS in Biochemistry from UCLA with Latin honors. His postgraduate training includes paediatrics at Children’s Hospital Los Angeles, followed by a prestigious fellowship in Allergy and Immunology at Stanford University. Additionally, he obtained a Diploma of Child Health from the UK. 📘👨‍🎓

Experience

Dr. Duque is a Clinical Assistant Professor at the University of Hong Kong and an Honorary Distinguished Professor at Guangzhou Medical University. His experience includes leadership roles at Hong Kong Children’s Hospital and Queen Mary Hospital. Previously, he served as a fellow at Stanford University, contributing to groundbreaking research in allergy and immunology. He has extensive experience in paediatric clinical care, academic mentorship, and collaborative research. 🏥📚

🏆 Awards and Honors

Dr. Duque has received numerous accolades, including Fellowships from the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Hong Kong Academy of Medicine. His research excellence has been recognized with prestigious grants and scholarships. Additionally, he serves in honorary academic roles at leading medical institutions in China and Hong Kong. His contributions to paediatric immunology and allergy are widely acclaimed. 🥇🌟

🔎 Research Focus

Dr. Duque’s research focuses on paediatric allergy, immunology, and infectious diseases. He investigates food allergies, anaphylaxis, and immune responses in paediatric patients. His work includes studies on drug allergies in Chinese children, neuropsychiatric syndrome, and immune risk factors. Through multidisciplinary research, he aims to advance treatment strategies and improve paediatric healthcare outcomes. His collaborations with global medical centers further enhance his impactful research. 🧬🔬

 

Publication Top Notes

  • 🧒 Outcomes of pediatric patients with suspected allergies to COVID-19 vaccines (2025)

  • 🧒 Development and validation of the Post-COVID Symptom Scale for Children/Youth (PCSS-C/Y) (2024)

  • 🧒 Seroepidemiology of Measles and Rubella Among Hong Kong Young Adults and the Humoral Responses of a Measles-Mumps-Rubella Booster (2024

  • 🧬 Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients (2024)

  • 🐟 Combined Integrative RNA-Seq and Serological sIgE Analysis Enhances Understanding of Fish Allergen Profiles (2024)

  • 🐟 Fish Allergenicity Ladder and Parvalbumin Epitopes for Predicting Clinical Cross-reactivity and Reintroduction (2024)

  • 🦠 PD1+CD4+ T cells promote receptor editing and suppress autoreactivity of CD19+CD21low B cells (2024)

  • 💉 Effectiveness of inactivated COVID-19 vaccine CoronaVac in children aged less than 3 years old during Omicron wave in Hong Kong (2024)

  • 🐟 Real-World Sensitization and Tolerance Pattern to Seafood in Fish-Allergic Individuals (2024)

  • 🧬 Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond (2024)

 

Hadi Hassannia | Immunology | Best Researcher Award

Dr. Hadi Hassannia | Immunology | Best Researcher Award

Dr. Hadi Hassannia, Mazandaran University of Medical Sciences, Iran

Dr. Hadi Hassannia is a prominent researcher at the Amol Faculty of Paramedical Sciences and the Immunogenetic Research Center of Mazandaran University of Medical Sciences in Sari, Iran. His research focuses on cancer immunotherapy and vaccine development, with significant publications on tumor inhibition and insulin-producing cells from stem cells. Dr. Hassannia possesses advanced technical skills in genetic engineering, antibody production, and molecular techniques. His experience as a lab technician in diagnostic laboratories has enriched his practical knowledge in various fields, including hematology and immunology. He is committed to advancing cancer research and therapeutic approaches. 🧬🔬💉

 

Publication Profile

Google Scholar

Work Experience

Dr. Hassannia has a robust work history, having served as a lab technician in various diagnostic laboratories in governmental hospitals from 2009 to 2017. His practical experience in clinical settings enriches his research with a real-world perspective, further bridging the gap between laboratory findings and clinical applications.

Technical Skills

Dr. Hassannia possesses a diverse skill set that enhances his research capabilities:

Genetic Engineering: He has significant experience in genetic engineering, including protein manipulation and monoclonal antibody production.

Immunological Techniques: Proficient in advanced immunological techniques such as flow cytometry, Western blotting, and ELISA, he is well-equipped to conduct comprehensive immunological research.

Molecular Techniques: His expertise extends to molecular biology techniques like PCR and gene transfection, which are essential for cancer research and therapeutic development.

Laboratory Animal Handling: His experience with laboratory animals allows him to perform complex experiments, including tumor induction, vital for his research in cancer models.

 

Research Interests

Cancer Vaccine Development: His work in developing cancer vaccines contributes to the growing field of immunotherapy, which seeks to harness the body’s immune system to combat cancer.

Immunotherapy: He is engaged in research focused on immunotherapy approaches for cancer treatment, highlighting his commitment to improving patient outcomes.

Cancer-Related Inflammation: Understanding the role of inflammation in cancer progression is a critical area of his research, as it can lead to new therapeutic targets.

Tumor Metastasis: His interest in tumor metastasis is vital for understanding how cancer spreads and devising strategies to prevent it.

Conclusion

Dr. Hadi Hassannia’s extensive research experience, impressive publication record, and technical skills make him an exceptional candidate for the Best Researcher Award. His contributions to cancer research, particularly in immunotherapy and vaccine development, demonstrate his potential to impact the field significantly and advance medical science.

 

Publication Top Notes

  • CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice – Cited by: 165, Year: 2017 🧬
  • Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles – Cited by: 85, Year: 2016 📉
  • Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine – Cited by: 76, Year: 2020 💉
  • Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway – Cited by: 72, Year: 2019 🚀
  • Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine – Cited by: 67, Year: 2020 ⚔️
  • Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice – Cited by: 67, Year: 2018 🌱
  • Anti‐inflammatory and anti‐tumor effects of α-l-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model – Cited by: 59, Year: 2018 🌼
  • Myeloid-derived suppressor cells in B cell malignancies – Cited by: 59, Year: 2015 🦠
  • FOXP3 and TGF-β gene polymorphisms in allergic rhinitis – Cited by: 54, Year: 2011 🌿
  • Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet‐rich plasma composite nanofibers – Cited by: 53, Year: 2020 🧪

 

Roger KoggeEnang | Soil Science | Best Researcher Award

Dr. Roger Kogge Enang | Soil Science | Best Researcher Award

Dr. Gabriel Espinosa Carrasco, University of Dschang, Cameroon

Dr. Roger Kogge Enang is a strong candidate for the Best Researcher Award due to his extensive background and contributions in soil science and environmental research. Here’s why he stands out:

Publication profile

Orcid

Extensive Research Output:

Since 2016, Dr. Enang has been actively publishing, with at least two scientific articles per year. His research spans various critical areas in soil science, including soil classification, nutrient cycling, and pollution remediation.

Educational Background:

He holds a Ph.D. and MSc in Soil Science, and a BSc in Chemistry, with a specialization in environmental chemistry and soil fertility. His academic credentials underpin his solid research foundation.

Diverse Research Interests:

His research covers vital topics such as soil mineralogy, soil organic matter, and digital soil mapping. He has contributed significantly to understanding soil properties and their implications for agriculture and environmental management.

Professional Involvement:

Dr. Enang is an active member of several professional organizations, including the Cameroon Soil Science Society and the International Network on Soil Pollution. His roles in these organizations reflect his commitment to advancing the field.

Field and Laboratory Experience:

His practical experience includes extensive soil surveys, experimental design, and advanced laboratory analyses. This hands-on expertise enhances the applicability and impact of his research findings.

Notable Publications:

Dr. Enang has published numerous peer-reviewed articles in reputable journals, demonstrating his ability to contribute valuable knowledge to the scientific community.

Given his track record of impactful research, extensive publications, and professional dedication, Dr. Roger Kogge Enang is highly suitable for the Best Researcher Award.